CA ACR67

Legislature declares support for creating policies to decrease deaths from atherosclerotic cardiovascular disease (ASCVD), the leading cause of death in the United States.

Legislature emphasizes importance of enhanced public awareness of comprehensive cardiovascular screening programs to identify patients at risk of cardiovascular events earlier.

Legislature declares importance of statewide cardiovascular planning collaboration to improve screening, treatment, monitoring, and health outcomes for ASCVD patients.

Approximately 21,000,000 Americans have been diagnosed with ASCVD, with 2,008,100 California adults reporting heart disease, stroke, angina, or heart attack manifestations.

California spends an estimated $11.74 billion annually on direct medical expenses for ASCVD care, with national costs projected to reach $1.1 trillion by 2035.